Overview

Minocycline for Bipolar Depression

Status:
Completed

Trial end date:
2013-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate minocycline as a potential treatment for bipolar depression when added to a mood-stabilizing medication. Minocycline is an antibiotic that is approved for the treatment of infections and acne. Participation in this research study is expected to last 8 weeks, and includes five outpatient visits.

Phase:

Phase 4

Details

Lead Sponsor:

Icahn School of Medicine at Mount Sinai

Treatments:

Minocycline